NCT04265846 is a clinical trial of bifocal IOL in Presbyopia, sponsored by Peking University Third Hospital.

Who is sponsoring NCT04265846?

NCT04265846 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT04265846?

Interventions in NCT04265846: bifocal IOL, mix bifocal IOL, trifocal IOL, EDOF IOL, different IOLs, monofocal IOL, monofocal IOL.

What condition does NCT04265846 study?

NCT04265846 studies Presbyopia, Cataract Senile.

Is NCT04265846 still recruiting?

NCT04265846 is currently status unknown. Last updated 12 August 2022.

Last reviewed 2022-08-12 · How we verify

NCT04265846

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia

Status unknown Last updated 12 August 2022

What this trial tests

trial testing bifocal IOL in Presbyopia in 140 participants. Status unknown.

Timeline

31 May 2020

Primary endpoint
31 May 2022

1 November 2022

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	140
Start date	31 May 2020
Primary completion	31 May 2022
Estimated completion	1 November 2022
Sites	1 location across China

Drugs / interventions tested

bifocal IOL
mix bifocal IOL
trifocal IOL
EDOF IOL
different IOLs
monofocal IOL
monofocal IOL

Conditions studied

Presbyopia — all drugs for Presbyopia →
Cataract Senile — all drugs for Cataract Senile →

Sponsor

Peking University Third Hospital

Who can join

Adults 50 to 80, any sex, with Presbyopia or Cataract Senile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare postoperative Subjective and objective visual quality and economic efficiency of different Intraocular Lens(IOLs) implantation designed for the correction of presbyopia.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Cost-Effectiveness of Presbyopia Correction Among Seven Strategies of Bilateral Cataract Surgery Based on a Prospective Single-Blind Two-Center Trial in China.
Lan Q, Liu Y, Xu F, Li M, et al · · 2022 · cited 9× · PMID 36071311 · DOI 10.1007/s40123-022-00562-3
Comparison of binocular visual quality in six treatment protocols for bilateral cataract surgery with presbyopia correction: a prospective two-center single-blinded cohort study.
Lan Q, Xu F, Sun T, Zeng S, et al · · 2023 · cited 4× · PMID 37734409 · DOI 10.1080/07853890.2023.2258894
Comparison of visual outcomes of a diffractive trifocal intraocular lens and a refractive bifocal intraocular lens in eyes with axial myopia: a prospective cohort study.
Sun T, Liu Y, Gao Y, Tang C, et al · · 2022 · cited 4× · PMID 36266642 · DOI 10.1186/s12886-022-02626-1
Neurosensory binocular vision after bilateral implantation of an extended depth of focus intraocular lens with micro-monovision: a prospective cohort study.
Sun T, Zhao X, Liu Y, Lan Q, et al · · 2025 · cited 1× · PMID 40389895 · DOI 10.1186/s12886-025-04125-5

Verify or expand the search:

Other recruiting trials for Presbyopia

Currently open trials in the same condition.

NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04265846 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 12 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04265846.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing